Objective: To design a blood ordering schedule and explore the influencing factors of blood utilizing and ordering for tumor surgical patients.
Methods: For a total of 58 306 tumor surgical patients, 22 643 applications of blood ordering and 7430 person-times of blood utilization from October 2002 to May 2012 were retrospectively analyzed at Cancer Hospital of Chinese Academy of Medical Sciences. Their clinical profiles and test results were analyzed.
Results: The operative transfusion rate was 32.81%. According to the operation position and the blood transfusion and preparation data, the surgical blood ordering schedule of tumor patients was established. Patient gender, hemoglobin, hematocrit, platelet, total protein and albumin level test results had significant effect on the transfusion of red blood cells (OR = 0.797, 9.614, 1.949, 0.437,0.444, 2.038, all P < 0.05). Patient gender, hemoglobin, hematocrit, activated partial thromboplastin time, prothrombin time, albumin and total protein level test results had significant effect on the transfusion of plasma (OR = 0.851, 1.367, 1.801, 1.652, 2.922, 2.224, 1.362, all P < 0.05) .
Conclusion: For surgical tumor patients, blood ordering should be based upon the test results of routine blood, blood coagulation and protein level test results to ensure that blood transfusion is both rational and safe.